CHU Lille Hôpital Claude Huriez

Lille 59037

1 studies enrolling now · 4 studies all time

What they study most

Biliary Tract Cancer, Cholangiocarcinoma, Chronic Myelomonocytic Leukemia, Gallbladder Cancer, MDS, Moderately to Severely Active Crohn Disease, Myelodysplastic Syndromes, RAEB, Ulcerative Colitis

Studies at this site

• Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease — Recruiting now
• Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis — Completed
• Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L BTC — Stopped early
• Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts — Completed